Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice

BACKGROUND AND PURPOSE: Neuromedin U (NmU) may be a novel target for obesity treatment owing to its anorectic and energy expenditure enhancing effects. Although two receptors, NMU1 and NMU2, are both responsible for the NmU‐mediated anti‐obesity effects, the receptor agonist with the most appropriat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Pharmacol
Main Authors: Nagai, Hiroaki, Kaisho, Tomoko, Yokoyama, Kotaro, Asakawa, Tomoko, Fujita, Hisashi, Matsumiya, Kouta, Noguchi, Jiro, Tsuchimori, Kazue, Nishizawa, Naoki, Kanematsu‐Yamaki, Yoko, Dote, Katsuko, Inooka, Hiroshi, Sakamoto, Jun‐ichi, Ohtaki, Tetsuya, Asami, Taiji, Takekawa, Shiro
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5758400/
https://ncbi.nlm.nih.gov/pubmed/29057457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14077
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados